According to Rush University Medical Center, the Division of Digestive Diseases is using an application built by Cosmo ...

With financial support from Medtronic, the university’s new hub is intended to drive innovation in the medical device space.

2025 marks a key execution year in Cosmo’s Vision 2030, strengthening the Company’s foundations for scalable, innovation-driven growth across AI-enabled MedTech and pharma. Financial Highlights: High ...

Doctors in Chicago are testing immersive technology as part of a new clinical trial that could change how colon cancer is detected—and potentially expand to hospitals nationwide.

High quality growth: €104 million revenue at guidance midpoint (€102 to €107 million) with recurring revenues representing the majority of sales and accelerating year over year Strategic firepower: ...

AbbVie and Medtronic have a long history of raising their dividends and continue to have healthy free cash flow for further dividend growth.

(RTTNews) - Cosmo Pharmaceuticals N.V. (COPN.SW,CMOPF) reported strong preliminary unaudited results for 2025, highlighting continued revenue growth and a robust cash position. The company achieved ...

Medical device companies are increasingly evolving from hardware vendors to data-driven services organizations, unlocking new revenue opportunities and providing value-added insights to healthcare ...

Genius Electronic Optical (GSEO) announced on February 6, 2026, that its January 2026 revenue reached NT$2.515 billion (US$79 ...

Gun Runner filly, champion 2-year-old filly of 2025, drilled a half mile for trainer John Sadler at the Arcadia, Calif. track ...